Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Medchemexpress LLC (Rac)-ZLc-002 | 99.0% | 231.25 | 50 MG
SDP

Catalog No. 5000436751
Encompass_Preferred

(Rac)-ZLc-002 is an inhibitor of nNOS interaction with nitric oxide synthase 1 adaptor protein (NOS1AP). It suppresses inflammatory nociception and chemotherapy-induced neuropathic pain. Additionally, it synergizes with Paclitaxel to reduce tumor cell viability.

  • Reduces co-immunoprecipitation of NOS1AP with nNOS immunoprecipitated from primary cultured cortical neurons
  • Synergizes to reduce tumor cell viability
  • Attenuates mechanical and cold allodynia evoked by Paclitaxel
  • Reduces formalin-evoked nociceptive behavior and Fos-like immunoreactivity in the spinal dorsal horn
  • Attenuates chronic mild stress (CMS)‐induced anxiogenic behavior

Catalog No. 50-004-36751 Supplier Medchemexpress LLC Supplier No. HY12499650MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

(Rac)-ZLc-002 is an inhibitor of nNOS interaction with nitric oxide synthase 1 adaptor protein (NOS1AP). It suppresses inflammatory nociception and chemotherapy-induced neuropathic pain. Additionally, it synergizes with Paclitaxel to reduce tumor cell viability.

  • Reduces co-immunoprecipitation of NOS1AP with nNOS immunoprecipitated from primary cultured cortical neurons
  • Synergizes to reduce tumor cell viability
  • Attenuates mechanical and cold allodynia evoked by Paclitaxel
  • Reduces formalin-evoked nociceptive behavior and Fos-like immunoreactivity in the spinal dorsal horn
  • Attenuates chronic mild stress (CMS)‐induced anxiogenic behavior

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.